These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 27207103)

  • 1. The Porphobilinogen Conundrum in Prebiotic Routes to Tetrapyrrole Macrocycles.
    Taniguchi M; Ptaszek M; Chandrashaker V; Lindsey JS
    Orig Life Evol Biosph; 2017 Mar; 47(1):93-119. PubMed ID: 27207103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simple formation of an abiotic porphyrinogen in aqueous solution.
    Lindsey JS; Ptaszek M; Taniguchi M
    Orig Life Evol Biosph; 2009 Dec; 39(6):495-515. PubMed ID: 19472071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sorbent therapy of the porphyrias. V. Adsorption of the porphyrin precursors delta-aminolevulinic acid and porphobilinogen by sorbents in vitro.
    Winston SH; Tishler PV
    Methods Find Exp Clin Pharmacol; 1986 Apr; 8(4):233-7. PubMed ID: 3724299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biosynthesis of porphyrins and corrins.
    Battersby AR; McDonald E
    Philos Trans R Soc Lond B Biol Sci; 1976 Feb; 273(924):161-80. PubMed ID: 4835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissection of the early steps in the porphobilinogen synthase catalyzed reaction. Requirements for Schiff's base formation.
    Jaffe EK; Hanes D
    J Biol Chem; 1986 Jul; 261(20):9348-53. PubMed ID: 3722199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 13C NMR studies of methylene and methine carbons of substrate bound to a 280,000-dalton protein, porphobilinogen synthase.
    Jaffe EK; Markham GD
    Biochemistry; 1988 Jun; 27(12):4475-81. PubMed ID: 3166990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variations in porphobilinogen and 5-aminolevulinic acid concentrations in plasma and urine from asymptomatic carriers of the acute intermittent porphyria gene with increased porphyrin precursor excretion.
    Floderus Y; Sardh E; Möller C; Andersson C; Rejkjaer L; Andersson DE; Harper P
    Clin Chem; 2006 Apr; 52(4):701-7. PubMed ID: 16497943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectroscopic evidence for a porphobilinogen deaminase-tetrapyrrole complex that is an intermediate in the biosynthesis of uroporphyrinogen III.
    Rosé S; Frydman RB; de los Santos C; Sburlati A; Valasinas A; Frydman B
    Biochemistry; 1988 Jun; 27(13):4871-9. PubMed ID: 3262369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Travelling wave ion mobility mass spectrometry of 5-aminolaevulinic acid, porphobilinogen and porphyrins.
    Benton CM; Lim CK; Moniz C; Jones DJ
    Rapid Commun Mass Spectrom; 2012 Feb; 26(4):480-6. PubMed ID: 22279024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A LC-MS/MS method for the specific, sensitive, and simultaneous quantification of 5-aminolevulinic acid and porphobilinogen.
    Zhang J; Yasuda M; Desnick RJ; Balwani M; Bishop D; Yu C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Aug; 879(24):2389-96. PubMed ID: 21783436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normal reference ranges for urinary δ-aminolevulinic acid and porphobilinogen levels.
    Agarwal S; Habtemarium B; Xu Y; Simon AR; Kim JB; Robbie GJ
    JIMD Rep; 2021 Jan; 57(1):85-93. PubMed ID: 33473344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of porphobilinogen synthase from Pseudomonas aeruginosa in complex with 5-fluorolevulinic acid suggests a double Schiff base mechanism.
    Frère F; Schubert WD; Stauffer F; Frankenberg N; Neier R; Jahn D; Heinz DW
    J Mol Biol; 2002 Jul; 320(2):237-47. PubMed ID: 12079382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of porphyrin precursors, 5-aminolevulinic acid derivatives by isotachophoresis.
    Fukae R; Shioi Y; Sasa T
    Anal Biochem; 1983 Aug; 133(1):190-6. PubMed ID: 6638479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of glycerol and dextrose on porphyrin precursor excretion in acute intermittent porphyria.
    Bonkowsky HL; Magnussen CR; Collins AR; Doherty JM; Hess RA; Tschudy DP
    Metabolism; 1976 Apr; 25(4):405-14. PubMed ID: 1263834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catalytic mechanism of porphobilinogen synthase: the chemical step revisited by QM/MM calculations.
    Tian BX; Erdtman E; Eriksson LA
    J Phys Chem B; 2012 Oct; 116(40):12105-12. PubMed ID: 22974111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The chemistry of porphyrins and their precursors on the heme biosynthetic chain].
    Urata G
    Nihon Rinsho; 1995 Jun; 53(6):1319-28. PubMed ID: 7616643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of 5-aminolevulinic acid metabolism by uroporphyrinogen I in rat liver homogenate.
    Shivji A; Bernstein M
    Clin Biochem; 1985 Apr; 18(2):88-91. PubMed ID: 4017229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 13C NMR studies of porphobilinogen synthase: observation of intermediates bound to a 280,000-dalton protein.
    Jaffe EK; Markham GD
    Biochemistry; 1987 Jul; 26(14):4258-64. PubMed ID: 3663587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct and simultaneous quantitation of 5-aminolaevulinic acid and porphobilinogen in human serum or plasma by hydrophilic interaction liquid chromatography-atmospheric pressure chemical ionization/tandem mass spectrometry.
    Benton CM; Couchman L; Marsden JT; Rees DC; Moniz C; Lim CK
    Biomed Chromatogr; 2013 Feb; 27(2):267-72. PubMed ID: 23180457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of porphobilinogenase by porphyrins in Saccharomyces cerevisiae.
    Araujo LS; Lombardo ME; Batlle AM
    Int J Biochem; 1994 Dec; 26(12):1377-81. PubMed ID: 7890117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.